EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Quality of life in patients with CRB1 ‐associated retinal dystrophies: A longitudinal study

Jessica S Karuntu iD, Xuan-Thanh-An Nguyen iD, Mays Talib iD, Mary J van Schooneveld iD, Jan Wijnholds, Maria M van Genderen iD, Nicoline E Schalij-Delfos, Caroline C W Klaver iD, Magda A Meester-Smoor, L Ingeborgh van den Born, Carel B Hoyng, Alberta A H J Thiadens iD und 3 weitere

Acta Ophthalmologica · 2024

DOI: 10.1111/aos.15769 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Ophthalmologica, 2024. Verfasst von Jessica S Karuntu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Leiden University Medical Center, Leiden, The Netherlands. Hauptthemen laut MEDLINE: Quality of Life, Retinal Dystrophies, Eye Proteins, Membrane Proteins. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Bontius Stichting, Curing Retinal Blindness Foundation, Stichting Blindenhulp.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To assess the longitudinal vision‐related quality of life among patients with CRB1 ‐associated inherited retinal dystrophies.

Methods

In this longitudinal questionnaire study, the National Eye Institute Visual Function Questionnaire (39 items, NEI VFQ‐39) was applied at baseline, two‐year follow‐up, and 4‐year follow‐up in patients with pathogenic CRB1 variants. [Correction added on 20 November 2023, after first online publication: The preceding sentence has been updated in this version.] Classical test theory was performed to obtain subdomain scores and in particular ‘near activities’ and ‘total composite’ scores. The Rasch analysis based on previous calibrations of the NEI VFQ‐25 was applied to create visual functioning and socio‐emotional subscales.

Results

In total, 22 patients with a CRB1 ‐associated retinal dystrophy were included, […] with a median age of 25.0 years (interquartile range: 13–31 years) at baseline and mean follow‐up of 4.0 ± 0.3 years. [Correction added on 20 November 2023, after first online publication: The preceding sentence has been updated in this version.] A significant decline at 4 years was observed for ‘near activities’ (51.0 ± 23.8 vs 35.4 ± 14.7, p = 0.004) and ‘total composite’ (63.0 ± 13.1 vs 52.0 ± 12.1, p = 0.001) subdomain scores. For the Rasch‐scaled scores, the ‘visual functioning’ scale significantly decreased after 2 years (−0.89 logits; p = 0.012), but not at 4‐year follow‐up (+0.01 logits; p = 0.975). [Correction added on 20 November 2023, after first online publication: In the preceding sentence, “…after 4 years…” has been corrected to “…after 2 years…” in this version.] The ‘socio‐emotional’ scale also showed a significant decline after 2 years (−0.78 logits, p = 0.033) and 4 years (−0.83 logits, p = 0.021).

Conclusion

In the absence of an intervention, a decline in vision‐related quality of life is present in patients with pathogenic CRB1 variants at 4‐year follow‐up. Patient‐reported outcome measures should be included in future clinical trials, as they can be a potential indicator of disease progression and treatment efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Quality of LifeRetinal DystrophiesEye ProteinsMembrane ProteinsNerve Tissue ProteinsVisual AcuityHumansMaleFemaleAdultAdolescentYoung AdultFollow-Up StudiesSurveys and QuestionnairesSickness Impact Profile

Stichwörter der Autor:innen

CRB1National Eye Institute Visual Function Questionnaireinherited retinal dystrophypatient‐reported outcome measurequality of life

Substanzen

CRB1 protein, humanEye ProteinsMembrane ProteinsNerve Tissue Proteins

Autor:innen und Institutionen

  • Department of Ophthalmology, Leiden University Medical Center, Leiden, The Netherlands.
  • Department of Ophthalmology, Amsterdam UMC, Academic Medical Center, Amsterdam, The Netherlands.
  • The Netherlands Institute for Neuroscience (NIN-KNAW), Amsterdam, The Netherlands.
  • Bartiméus, Diagnostic Centre for complex visual disorders, Zeist, The Netherlands.
  • Department of Ophthalmology, University Medical Centre Utrecht, Utrecht, The Netherlands.
  • Department of Ophthalmology, Erasmus Medical Center, Rotterdam, The Netherlands.

ORCID-Profile: Jessica S Karuntu, Xuan-Thanh-An Nguyen, Mays Talib, Mary J van Schooneveld, Maria M van Genderen, Caroline C W Klaver, Alberta A H J Thiadens, Camiel J F Boon

Förderung

  • Bontius Stichting
  • Curing Retinal Blindness Foundation
  • Stichting Blindenhulp
  • Stichting Retina Fonds
  • Stichting Steunfonds Uitzicht

Zitieren

APA

Karuntu, J. S., Nguyen, X. T., Talib, M., van Schooneveld, M. J., Wijnholds, J., van Genderen, M. M., Schalij-Delfos, N. E., Klaver, C. C. W., Meester-Smoor, M. A., van den Born, L. I., Hoyng, C. B., Thiadens, A. A. H. J., Bergen, A. A., van Nispen, R. M. A., & Boon, C. J. F. (2024). Quality of life in patients with CRB1 ‐associated retinal dystrophies: A longitudinal study. Acta Ophthalmologica. https://doi.org/10.1111/aos.15769

Vancouver

Karuntu JS, Nguyen XT, Talib M, van Schooneveld MJ, Wijnholds J, van Genderen MM, et al. Quality of life in patients with CRB1 ‐associated retinal dystrophies: A longitudinal study. Acta Ophthalmologica. 2024. doi:10.1111/aos.15769

BibTeX
@article{Karuntu2024,
  author = {Karuntu, Jessica S and Nguyen, Xuan-Thanh-An and Talib, Mays and van Schooneveld, Mary J and Wijnholds, Jan and van Genderen, Maria M and Schalij-Delfos, Nicoline E and Klaver, Caroline C W and Meester-Smoor, Magda A and van den Born, L Ingeborgh and Hoyng, Carel B and Thiadens, Alberta A H J and Bergen, Arthur A and van Nispen, Ruth M A and Boon, Camiel J F},
  title = {Quality of life in patients with CRB1 ‐associated retinal dystrophies: A longitudinal study},
  journal = {Acta Ophthalmologica},
  year = {2024},
  doi = {10.1111/aos.15769}
}
Kostenlos starten →